The Effect of Ultrasound-guided Ropivacaine Combined with Dexmedetomidine in Fascia Iliaca Compartment Block for Postoperative Analgesia After Lower Limb Fracture Operation

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-15006122

Enrollment

Unknown

Registered

2015-03-16

Start date

2015-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Fracture

Interventions

Group R:Use ropivacaine

Group RD :use dexmedetomidine and ropivacaine

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with Lower Limb Fracture, ASA I-II grade,BMI 18~24 kg/m2.

Exclusion criteria

Exclusion criteria: Patients can not cooperate and exchange;Severe liver, kidney and blood system dysfunction; Formulation ingredients used in this study for patients with a history of allergy; Block failure patients.

Design outcomes

Primary

Measure	Time frame
VAS;OAA/S;CRP;	—

Countries

China

Contacts

Public ContactCheng Fang

chengfang-1991@163.com+86 13851260712

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026